Orexigen Therapeutics Inc

FRA:JXS1 (USA)  
€ 0.00 (0%) Jun 10
At Loss
Market Cap:
€ 19.00K ($ 20.00K)
Enterprise V:
€ 19.00K ($ 20.00K)
Volume:
-
Avg Vol (2M):
1.98K

Business Description

Description
Orexigen is an emerging pharmaceutical company, focusing on developing neuroscience drugs. The company screens older drugs seeking synergistic actions. The company's most advanced drug candidates target obesity.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
14-Day RSI 19.2

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History
FCF Yield % -293142

Financials

FRA:JXS1's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Orexigen Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 67.708
EPS (TTM) (€) -8.88
Beta 0
Volatility % 112.06
14-Day RSI 19.2
14-Day ATR (€) 0
20-Day SMA (€) 0.03
12-1 Month Momentum % 0
52-Week Range (€) 0 - 0.18
Shares Outstanding (Mil) 18.89

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Orexigen Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Orexigen Therapeutics Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Orexigen Therapeutics Inc Frequently Asked Questions

What is Orexigen Therapeutics Inc(FRA:JXS1)'s stock price today?
The current price of FRA:JXS1 is €0.00. The 52 week high of FRA:JXS1 is €0.18 and 52 week low is €0.00.
When is next earnings date of Orexigen Therapeutics Inc(FRA:JXS1)?
The next earnings date of Orexigen Therapeutics Inc(FRA:JXS1) is .
Does Orexigen Therapeutics Inc(FRA:JXS1) pay dividends? If so, how much?
Orexigen Therapeutics Inc(FRA:JXS1) does not pay dividend.

Press Release

Subject Date
No Press Release